Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Stifel analyst Stephen Willey initiated coverage on Lyell Immunopharma Inc (NASDAQ:LYEL) with a Buy rating and announced a price target of $36. Lyell Immunopharma closed at $13.45 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Andres Y. Maldonado initiated coverage on Immuneering Corp (NASDAQ:IMRX) with a Buy rating and announced a price target of $14. Immuneering shares closed at $4.39 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Atrium Therapeutics Inc (NASDAQ:RNA) with a Buy rating and announced a price target of $25. Atrium Therapeutics closed at $11.74 on Wednesday. See how other analysts view this stock.

Considering buying LYEL stock? Here’s what analysts think:

Photo via Shutterstock